英文_OECD_2D碳化钛MXenes_先进材料案例研究报告_52页_1mb

2D Titanium Carbide MXenes: Case Study Summary

Core Content

This report presents a case study on 2D titanium carbide MXenes, focusing on safety, sustainability, and regulatory implications. Conducted by the OECD Working Party on Manufactured Nanomaterials (WPMN), the study aimed to identify potential issues and propose follow-up actions to support regulatory preparedness and safe development of these materials.

Main Findings

1. Overview of MXenes

• Definition: MXenes are a family of 2D transition metal carbides and nitrides, first discovered in 2011.
• General Formula: $M_{n+1}X_nT_x$, where M is a transition metal (groups 3–6), X is carbon or nitrogen, and T represents surface termination groups.
• Properties: MXenes are hydrophilic, electrically conductive, strong, and have tunable surface groups, making them suitable for applications in energy storage, catalysis, electromagnetic shielding, biomedical (e.g., photothermal therapy), and environmental remediation.
• Challenges: MXenes are prone to oxidation and irreversible lamellar stacking.

2. Current State of Research

• Literature Review: A comprehensive review of scientific literature was conducted using PubMed, Embase, and Scopus, resulting in 37 publications considered for the Early4AdMa assessment.
• Study Quality: Many studies lack standardization in terms of material characterization, dispersion methods, and benchmarking, which hinders risk assessment and regulatory decision-making.
• Research Focus: Most research has focused on titanium carbide MXenes, particularly $Ti_3C_2T_x$, though other types such as $V_2CT_x$, $Mo_2CT_x$, $Nb_4C_3T_x$, and $V_2NT_x$ have also been studied.

3. Identified Issues

Human Health Safety

• Toxicity: No clear evidence of high acute toxicity, but information gaps prevent definitive conclusions.
• Study Limitations: Limited quality of experimental studies, including inadequate dispersion methods, poor characterization, and excessive exposure concentrations.
• Biological Fate: Uncertainty about transformation products and biokinetics in the human body.
• Toxicological Gaps: Lack of data on pulmonary hazards, genotoxicity, and long-term effects (oral and inhalation).

Environmental Safety

• Exposure and Fate: Limited understanding of environmental release and fate of MXenes.
• Assessment Challenges: Existing test methods may not be suitable for characterizing hazards and exposure due to the unique properties of MXenes.

Sustainability

• Raw Materials: Concerns about the sustainability of raw materials and resource use.
• Production and Use: Limited information on environmental impacts at industrial scale, recyclability, and reusability.
• Life Cycle: Need for more data on the full life cycle of MXenes, including production, transport, and end-of-life.

Regulatory Frameworks

• Applicability: Some existing regulations may not be suitable for MXenes due to their unique properties.
• Test Methods: Current OECD test guidelines may not be adequate for assessing hazards and exposure of MXenes.
• Benchmarking: Lack of standardized benchmark materials hinders comparative analysis across studies.

Key Recommendations and Follow-Up Actions

Workshop Overview

4.1 Workshop Details

• Date and Time: May 28, 2024, 12:00–16:00 CET (Zoom).
• Participants: 39 participants from government, academia, and regulatory bodies; industry and sustainability experts were underrepresented.
• Agenda: The workshop included presentations on the case study, introduction to Early4AdMa, and discussions on human health, environmental safety, sustainability, and regulatory frameworks.

4.2 Workshop Outcomes

• Discussion Highlights: Participants emphasized the need for improved study quality, better characterization methods, and the development of standardized test protocols.
• Consensus: While consensus on terminology was not reached, the workshop identified key areas for further research and regulatory development.
• Follow-Up Actions: A list of suggested actions was presented, with a focus on improving data collection, enhancing transparency, and aligning with global standards.

Conclusion

This case study highlights the need for a coordinated, science-driven approach to assess the safety, sustainability, and regulatory readiness of titanium carbide MXenes. The findings serve as a foundation for future discussions and actions within the OECD WPMN and other stakeholders. The Early4AdMa tool was effectively used to identify potential issues and propose follow-up actions, demonstrating its utility in regulatory preparedness for advanced materials.

The report underscores the importance of transparency, standardization, and international cooperation in the safe development and sustainable use of MXenes. It is intended to support informed decision-making by industry, academia, and regulatory authorities in the context of emerging nanomaterials and advanced materials.